Pharmaceuticals · Pharmaceuticals: Major · NSE: VILINBIO · data 2026-10-30

Vilin Bio Med Ltd.

₹52.05+3.17% on 30 OctHealth: Strong 7.5/10

Dec 2025Low ₹18.95 · High ₹60+158.3%

In plain words

Price: 14.6% below its 52-week high of ₹60.95.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹52.05

Market cap

₹70 cr

P/E

40.9

P/B

2.8

ROE

7.5%

ROCE

11.3%

Debt / equity

0.01

Dividend yield

0.00%

1-year return

106.5%

52-week high

₹60.95

52-week low

₹18.95

Operating margin

6.9%

Growth

Revenue (last 12 months)	₹42 cr
Net profit (last 12 months)	₹2 cr
Sales growth, 3 years (yearly)	50.8%
Profit growth, 3 years (yearly)	15.7%

Smart-money activity

5/100 · Weak over the last ~60 sessions

Delivery vs usual 0/30: No stored daily delivery history for this stock (0 points).
Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
Promoter pledges 5/5: No promoter pledge filings in 90 days.

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Common questions

Is Vilin Bio Med Ltd. debt-free?

Its latest reported debt-to-equity ratio is 0.01, which is very low.

What is Vilin Bio Med Ltd.'s P/E ratio?

About 40.9, based on the last 12 months' earnings and a price of ₹52.05 (data 2026-10-30).

What is the 52-week high and low of Vilin Bio Med Ltd.?

The 52-week high is ₹60.95 and the 52-week low is ₹18.95.

Similar companies

Vaishali Pharma Ltd. (VAISHALI) · Sunil Healthcare Ltd. (SUNLOC) · Onyx Biotec Ltd. (ONYX) · Zenith Drugs Ltd. (ZENITHDRUG) · Vivimed Labs Limited (VIVIMEDLAB)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open VILINBIO in NSE Scanner →